Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Consumer Perspectives on Healthcare’s Basic Deliverables of Quality & Experience are Declining


“Healthcare organizations can’t afford to lose sight of supporting people’s interest in their own health and well-being, their physical needs and their desire for positive outcomes, while being treated with respect and being addressed as a person”

The Beryl Institute and Ipsos released findings from the 13th edition of PX Pulse, a survey to track current perspectives on patient experience in healthcare across the United States. This report trends data related to the consumer experience from data first collected pre-pandemic in December 2019 through the second quarter of 2023. This issue reveals that while quality of care and overall care experience slipped since last quarter, trust in healthcare services and providers remains high.

Key findings include:

  • Consumer perception of quality and overall experience are slowly declining.
  • Cost and affordability remain important issues to consumers, while access to quality hospitals and treatments appeared again this quarter as one of the top five most important issues.
  • The importance of experience remains high at 95% with consumers noting health and well-being as the most important reason why.
  • While trust in healthcare is high, creating stronger relationships with patients, providers and the community served may be addressed by a strengthened commitment to the human experience.

“Healthcare organizations can’t afford to lose sight of supporting people’s interest in their own health and well-being, their physical needs and their desire for positive outcomes, while being treated with respect and being addressed as a person,” said Jason A. Wolf, PhD, CPXP, President & CEO, The Beryl Institute. “These are the critical levers that will ensure experience can be elevated and reinforce how quality elements are truly central to the overall experience organizations provide.”

To access the latest PX Pulse report, visit here.

###

About the PX Pulse Survey

The Beryl Institute – Ipsos PX Pulse represents a first-of-its-kind effort to elevate understanding of the current perspectives on patient experience in U.S. healthcare.

This effort regularly captures healthcare consumer perspectives of patient experience in the United States, determines the practices and processes that have the greatest impact and influence on healthcare consumers, and tracks how the market sees patient experience evolving over time.

About The Beryl Institute

The Beryl Institute is a global community of healthcare professionals and experience champions committed to transforming the human experience in healthcare. As a pioneer and leader of the experience movement and patient experience profession for more than a decade, the Institute offers unparalleled access to unbiased research and proven practices, networking and professional development opportunities and a safe, neutral space to exchange ideas and learn from others.

We define the patient experience as the sum of all interactions, shaped by an organization’s culture, that influence patient perceptions across the continuum of care. We believe human experience is grounded in the experiences of patients and families, members of the healthcare workforce and the communities they serve.

About Ipsos

Ipsos is one of the largest market research and polling companies globally, operating in 90 markets and employing over 18,000 people.

Our passionately curious research professionals, analysts and scientists have built unique multi-specialist capabilities that provide true understanding and powerful insights into the actions, opinions and motivations of citizens, consumers, patients, customers or employees. Our 75 business solutions are based on primary data from our surveys, social media monitoring, and qualitative or observational techniques. “Game Changers” – our tagline – summarizes our ambition to help our 5,000 clients navigate with confidence our rapidly changing world.

Founded in France in 1975, Ipsos has been listed on the Euronext Paris since July 1, 1999. The company is part of the SBF 120 and the Mid-60 indexes and is eligible for the Deferred Settlement Service (SRD).

ISIN code FR0000073298, Reuters ISOS.PA, Bloomberg IPS:FP http://www.ipsos.com

The publication of these findings abides by local rules and regulations.

For more information on Ipsos’ patient experience and healthcare contributions, you can follow Ipsos on LinkedIn and Twitter (@ipsosus).

Share article on social media or email:

Prevent Blindness Declares July as Dry Eye Awareness Month to Educate Public on Eye Disease that Affects more than 16 Million Americans


Prevent Blindness has declared July as Dry Eye Awareness Month to help educate the public on the eye disease, including risk factors, symptoms, and treatment options.

“Dry eye is a serious condition that may have long-term effects on eye health, if left untreated,” said Jeff Todd, president and CEO of Prevent Blindness.

Nearly 16 million Americans have dry eye, according to the National Eye Institute (NEI). Dry eye occurs when there is not enough tear film produced, the tear film is not draining properly from the eye, or the tear film is not the quality needed to maintain the health of the eye. If left untreated, dry eye can cause damage to the cornea.

In an effort to educate the public on dry eye, Prevent Blindness, the nation’s leading nonprofit eye health organization, has declared July as “Dry Eye Awareness Month.” Information is available on dry eye risk factors, symptoms, and treatment options through a variety of resources, including fact sheets and shareable social media graphics, available in English and Spanish, and a dedicated web page: https://preventblindness.org/understanding-dry-eye.

This year, Prevent Blindness is offering a new episode of the Focus on Eye Health Expert Series, “Dry Eye and Meibomian Gland Dysfunction (MGD),” featuring April Jasper, OD, FAAO, Advanced Eyecare Specialists. Dr. Jasper shares her unique experience as a dry eye patient as well as an eyecare provider. MGD is a condition when the eyelid glands do not produce enough oil, or it is of poor quality.

For the third consecutive year, OCuSOFT ® Inc., a privately-held eye and skin care company dedicated to innovation in eyelid hygiene and ocular health, is partnering with Prevent Blindness in support of Dry Eye Awareness Month.

Risk factors for dry eye include:

  • Being more than 50 years old
  • Hormonal changes
  • Refractive surgery (for example, Lasik)
  • Inflammation of the eyelids
  • Environmental conditions, such as allergies, exposure to smoke, or a dry climate
  • Prolonged use of digital screens, such as computers
  • Wearing contact lenses
  • Medical conditions such as diabetes, thyroid eye disease, rheumatoid arthritis, lupus, Sjogren’s syndrome, and certain other autoimmune diseases

Additionally, taking certain medicines increases the risk of dry eye. According to the American Academy of Ophthalmology, these include diuretics (water pills) for high blood pressure, beta-blockers, for heart problems or high blood pressure, allergy and cold medicines (antihistamines), sleeping pills, anxiety and antidepressant medicines, and heartburn medicines. Patients must inform their eyecare professional of all medications they are taking in order to treat dry eye and other eye conditions effectively.

“Dry eye is a serious condition that may have long-term effects on eye health, if left untreated,” said Jeff Todd, president and CEO of Prevent Blindness. “We encourage patients to talk with their eye doctors about their dry eye symptoms, and work together to form an effective treatment plan to keep eyes healthy for years to come.”

For more information on dry eye, please visit the Prevent Blindness resource page at PreventBlindness.org/understanding-dry-eye.

About Prevent Blindness

Founded in 1908, Prevent Blindness is the nation’s leading volunteer eye health and safety organization dedicated to fighting blindness and saving sight. Focused on promoting a continuum of vision care, Prevent Blindness touches the lives of millions of people each year through public and professional education, advocacy, certified vision screening and training, community and patient service programs and research. These services are made possible through the generous support of the American public. Together with a network of affiliates, Prevent Blindness is committed to eliminating preventable blindness in America. For more information, visit us at PreventBlindness.org, and follow us on Facebook, Twitter, Instagram, LinkedIn and YouTube.

###

Share article on social media or email:

The Northeast’s Leading Provider of LASIK Eye Surgery


“With LASIK by OCLI Vision, we bring unparalleled patient care and superior LASIK eye surgery to the Northeast. Our cutting-edge technology and affordable LASIK cost sets us apart, but it’s our experienced team that truly elevates our standard of care and innovation for each deserving community.”

LASIK by OCLI Vision, a new division of OCLI Vision, has set out to become the northeast’s premier provider of LASIK eye surgery services. With a steadfast commitment to patient satisfaction and continuous innovation, OCLI Vision stands poised to redefine the standard of LASIK surgery across the Northeast.

In the growing LASIK eye surgery market, LASIK by OCLI Vision is well-positioned to meet the increasing need with expert services. A team of world-class surgeons will provide extensive LASIK eye surgery services, including Bladeless, monovision, custom, and photorefractive keratectomy (PRK) LASIK eye surgery. The opening of the new LASIK by OCLI Vision centers across the Northeast marks a significant step forward in the growth of New York LASIK eye surgery and LASIK surgery Connecticut, among other states.

“LASIK aims to correct refractive errors, reducing dependency on eyeglasses,” stated Dr. Eric D. Donnenfeld, an esteemed LASIK surgeon at OCLI Vision and recently named Newsweek’s top ophthalmologist for the third consecutive year. “At LASIK by OCLI Vision, we pride ourselves in leading the field in utilizing advanced LASIK technology.”

When choosing LASIK by OCLI Vision, patients will have access to the industry’s best surgeons, all of whom are committed to patient safety and comfort and delivering the most advanced LASIK services in the country. The LASIK by OCLI Vision team of internationally recognized professionals stands ready to deliver the enormous benefits of LASIK treatment by utilizing the latest technology, including the CustomVue™ Wavescan machine as well as the Wavelight Laser. With the plethora of LASIK service providers now available, choosing the top-rated surgeons at LASIK by OCLI Vision is the best way to ensure excellent results, access to high-quality care, a fair LASIK cost, and innovative approaches.

With comprehensive information on their website and numerous partners, LASIK by OCLI Vision ensures that potential patients can learn about LASIK and the benefits of LASIK, as well as understand the LASIK cost, and schedule appointments at their nearest location.

“With LASIK by OCLI Vision, we bring unparalleled patient care and superior LASIK eye surgery to the Northeast. Our cutting-edge technology and affordable LASIK cost sets us apart, but it’s our experienced team that truly elevates our standard of care and innovation for each deserving community.” Dr. Donnenfeld said.

For more information on New York LASIK eye surgery, LASIK surgery Connecticut, or LASIK in Pennsylvania and West Virginia, please visit lasikbyoclivision.com.

Since 2017, Spectrum Vision Partners has served as the management services organization for OCLI Vision, and now LASIK by OCLI Vision. As the Mid-Atlantic and New England’s premier management services organization for ophthalmology practices and ambulatory surgery centers, SVP provides services including, human resources, marketing and patient retention services, finance and accounting services, and much more.

About LASIK by OCLI Vision

LASIK by OCLI Vision (http://www.lasikbyoclivision.com) is the northeast’s foremost provider of LASIK surgery services from the regions most respected LASIK eye surgeons. LASIK by OCLI Vision is the newest subsidiary of OCLI Vision and was founded to improve patient access to internationally recognized surgeons and further industry innovations through dedicated LASIK services. Featuring a wide variety of LASIK eye surgery services and top-notch surgeons from the OCLI Vision group, LASIK by OCLI Vision is a world-renowned, multi-location LASIK practice dedicated to the highest quality service and patient care.

About OCLI Vision

Founded in 1997, OCLI Vision (http://www.ocli.net) is one of the leading ophthalmology practices in the United States. The practices of OCLI Vision offer eye care services at locations throughout Connecticut, New Jersey, New York, and Pennsylvania. OCLI is led by a large group of highly skilled ophthalmologists and optometrists in each major sub-specialty of eye care, who provide comprehensive eye care services, including treatment for cataracts, corneal disease, glaucoma, retinal disease, oculoplastics, refractive surgery, and neuro-ophthalmology.

About Spectrum Vision Partners

Spectrum Vision Partners (SVP) (http://www.spectrumvisionpartners.com) is a leading management services organization, serving the ophthalmology sector. With over 1,400 employees providing world-class practice management and administrative solutions to a network of nationally renowned, multi-specialty ophthalmologists in New York, New Jersey, Connecticut, Pennsylvania and West Virginia, SVP supports over 50 clinic locations, five state-licensed ambulatory surgery centers, and over 150 surgeons, doctors and other medical professionals. SVP provides a comprehensive set of business support functions, including billing and collections, credential services, marketing, physician recruitment, ASC development, financial and accounting services, benefits and payroll management and information technology. The company’s corporate service center is located at 825 East Gate Boulevard, Suite 111, Garden City, NY 11530.

Share article on social media or email:

American Canadian School of Medicine Receives Another Accreditation


Ramin Ahmadi, M.D., MPH

“Collaborating with a professional and high-quality accrediting organization like ACCM has enabled us to improve our processes, protocols, and overall program design,” said Dr. Ahmadi.

The American Canadian School of Medicine (ACSOM) is proud to announce that it has successfully completed the initial accreditation process by the Accreditation Commission on Colleges of Medicine (ACCM), a globally recognized organization. With the accreditation obtained last month by Independent Agency for Accreditation and Rating (IAAR), ACSOM will now begin its inaugural class with two accreditations that are recognized by the World Federation of Medical Education (WFME). With the dual WFME recognition, ACSOM graduates are eligible to receive an Educational Commission for Foreign Medical Graduates (ECFMG) certificate, a requirement to pursue residency training in North America.

Dr. Ramin Ahmadi, MD, MPH, former Associate Clinical Faculty at Yale School of Medicine and founding Dean of ACSOM, expressed his satisfaction with the accreditation process, “Meeting ACCM’s quality standards and receiving WFME recognition is an immense achievement for ACSOM.”

During the accreditation process, ACCM reported that ACSOM has the infrastructure to successfully operate a medical school. ACSOM sits on a 30-acre campus that includes state-of-the-art classrooms, labs, and simulated patient care environments, equipped with the latest technology and resources to support student learning and development.

With the latest accreditation, ACSOM students can progress through their medical education journey all the way through to residency unhindered. Key to ACSOM’s curriculum is the integration of clinical medicine at the start of the students’ academic journey and continues through their clerkships at partner teaching hospitals in the United States and Canada. With the latest accreditation, ACSOM graduates will meet the conditions for ECFMG certification, a requirement by the US Department of Education to pursue residency training in the United States as well as the gold standard to practice in the rest of North America.

“This accreditation has not only assured our graduates of their eligibility for residency training in the United States and Canada but has also allowed us to refine and enhance our educational program. Collaborating with a professional and high-quality accrediting organization like ACCM has enabled us to improve our processes, protocols, and overall program design,” said Dr. Ahmadi.

The positive development has already sparked a tremendous surge in student applications. Ms. Greene, the Director of Admissions at ACSOM, reported a daily ten-fold increase in the number of applications over the past five days. “We anticipate a further surge in the number of applicants in the coming weeks,” she remarked. “To ensure a seamless admissions process, we have prepared a comprehensive plan and allocated adequate staff resources to handle the influx of applications promptly and efficiently.”

ACSOM is the first non-profit international medical school in the Caribbean, established in collaboration with the government of Dominica. With a dedicated team of full-time physician faculty for small group teaching, ACSOM provides a supportive and engaging learning environment. Moreover, ACSOM boasts an impressive roster of adjunct faculty members who bring their training and experience from revered medical schools such as Yale University School of Medicine, Weil Cornell Medical College, New York University, Penn State University’s Milton S. Hersey Medical Center, SUNY Downstate Medical Center and Western University in Canada.

American Canadian School of Medicine

The American Canadian School of Medicine (ACSOM) is a non-profit international medical school based in Dominica. It offers a comprehensive medical education program with a focus on preparing students for residency training in North America. ACSOM is accredited by the Independent Agency for Accreditation and Rating (IAAR) and the Accreditation Commission on Colleges of Medicine (ACCM) and recognized by the World Federation of Medical Education (WFME). For more information, visit http://www.acsom.edu.dm

Share article on social media or email:

HMP Global’s 2023 Evolution of Psychotherapy makes its grand return to Anaheim, California for a 5-day, practice-changing conference


The meeting will be held December 12-17 at the Anaheim Convention Center

HMP Global’s Evolution of Psychotherapy conference is making its grand return to Anaheim, California for a five-day integrated forum where the living legends of psychotherapy, breakout thinkers, and on-the ground professionals will connect, engage, support, and reinvigorate attendees’ passion for the field.

The meeting will be held December 12-17 at the Anaheim Convention Center and is the official meeting of the Milton H. Erickson Foundation. Described as “a golden opportunity for mental health professionals,” the faculty lineup at the 2023 meeting includes some of the world’s foremost psychotherapists and experts in the field of mental health.

Evolution of Psychotherapy is the premier event for psychotherapy education with an educational program featuring more than 90 sessions led by 35-plus world-renowned speakers. Educational tracks include clinical demonstrations, conversation hours, invited addresses, great conversation sessions, speeches, invited panels, in-depth workshops, keynotes, and two pre-conferences.

“This is the first time since 2017 that Evolution of Psychotherapy will be held in Anaheim,” said Dr. Jeff Zeig, Director of the Milton H. Erickson Foundation. “In developing the educational agenda, we look for commonalities that underly successful clinical work and we develop sessions that will fit the needs of practicing clinicians. Our 2023 meeting will examine the current challenges in mental health, and both the research-based best practices and novel approaches to improving patient care and outcomes. Evolution is the most anticipated psychotherapy event of the year and a once-in-a-lifetime experience that no one should miss.”

Announced keynote speakers for 2023 include:


  •     John Gottman, PhD, and Julie Gottman, PhD, psychologists with expertise in marital stability and divorce prediction
  •     Temple Grandin, PhD, best-selling author and researcher on visual thinking
  •     Rob Kapilow, composer, conductor, author, music commentator
  •     Otto F. Kernberg, MD, FAPA, legendary psychoanalyst and leading researcher on personality disorders
  •     Cloe Madanes, LIC, HDL, innovator and teacher of family and strategic therapy
  •     Christina Maslach, PhD, pioneering researcher on the definition, predictors, and measurement of job burnout
  •     Donald Meichenbaum, PhD, founding expert on cognitive behavioral therapy
  •     Martin Seligman, PhD, leading authority in the fields of positive psychology, resilience, learned helplessness, depression, optimism, and pessimism
  •     Dan Siegel, MD, award-winning educator, co-director of the Mindful Awareness Research Center at UCLA
  •     David Whyte, renowned poet, philosopher, and speaker

Participants can earn more than 125 continuing education credits at this year’s meeting. The conference is open to professionals in mental health and health-related fields, including marriage and family therapists, clinical and counseling psychologists, psychiatric social workers, pastoral counselors, psychotherapists, psychiatrists, physicians, nurse practitioners, counselors, and graduate students.

To view the full agenda, speaker lineup and to register, visit evolutionofpsychotherapy.com.

ABOUT HMP GLOBAL 

HMP Global is the force behind Healthcare Made Practical — and is an omnichannel leader in healthcare content, events, and education, with a mission to improve patient care. The company produces accredited medical education events — in person and online via its proprietary VRTX virtual platform — and clinically relevant, evidence-based content for the global healthcare community across a range of therapeutic areas. Its brands include the HMP Global Learning Network, healthcare’s most comprehensive source for news and information; Psych Congress, the largest independent mental health meeting in the U.S.; the Evolution of Psychotherapy, the world’s largest independent educational event for mental health professionals; the Leipzig Interventional Course (LINC), the leading, global gathering for interdisciplinary cardiovascular specialists; EMS World Expo, North America’s largest EMT and paramedic event; and the Symposium on Advanced Wound Care (SAWC), the largest wound care meeting in the world. For more information, visit hmpglobal.com.

Share article on social media or email:

Genedata Announces Licensing Agreement with Gilead Sciences to Enhance Data Science Innovation in Discovery Research


Digitalizing Biopharma R&D

Utilizing Genedata Profiler will enhance our capabilities for integration and analysis of large-scale multi-modal datasets as we continue to accelerate research for the discovery of transformative medicines. Li Li, Executive Director, Research Data Sciences at Gilead

Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced a licensing agreement with Gilead Sciences, Inc. to help the company leverage the power of multi-omics data in the discovery of life-changing therapeutics across multiple indications. The agreement includes a software license to Genedata Profiler®, a domain-specific, state-of-art data integration and analytics platform, and access to consulting resources to support the adoption and integration of the solution within the company’s infrastructure.

“At Gilead, we work every day to discover innovative therapeutics for people with life-threatening diseases,” said Li Li, Executive Director, Research Data Sciences at Gilead. “Utilizing Genedata Profiler will enhance our capabilities for integration and analysis of large-scale multi-modal datasets as we continue to accelerate research for the discovery of transformative medicines.”

As a comprehensive, end-to-end computational solution, Genedata Profiler enables biopharmaceutical organizations to conduct data-rich discovery and translational research and make more informed decisions, ultimately supporting the development of more effective, targeted treatments. It empowers data scientists to decipher complex patterns associated with a specific disease from Next Generation Sequencing (NGS) and other high-dimensional data, facilitating target identification and evaluation and biomarker research for a range of therapeutic indications.

The main benefits of Genedata Profiler include:


  • A centralized data storage place to enable self-service access to a large variety of multi-omics data from past and ongoing experiments,
  • Configurable automated workflows to streamline processing, integration, publishing, and analysis of a large amount of high-dimensional data,
  • Advanced, yet intuitive analytical and visualization methods to help derive novel scientific insights,
  • Efficient data-sharing tools with fine-grained access control to data to ensure seamless, yet secure collaboration across and beyond organizational units.

Beyond software, Genedata provides scientific domain expertise and 26 years of experience in supporting the biopharma industry in increasing the productivity and quality of their research output through digital transformation.

“We are excited to have signed Gilead Sciences to our rapidly growing customer list for our Genedata Profiler platform,” said Othmar Pfannes, Ph.D., CEO of Genedata. “Genedata Profiler democratizes access to R&D data and includes fit-for-purpose analytics, while automating highly complex data operations, all key requirements for enabling biopharmaceutical organizations to generate precision medicines as efficiently as possible.”

About Gilead Sciences

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.

http://www.gilead.com

LinkedIn | Twitter

About Genedata

Genedata transforms data into intelligence with innovative software solutions that incorporate extensive biopharma R&D domain knowledge. Multinational biopharmaceutical organizations and cutting-edge biotechs around the globe rely on Genedata to digitalize and automate data-rich and complex R&D processes. From early discovery all the way to the clinic, Genedata solutions help maximize the ROI in R&D expenditure. Founded in 1997, Genedata is headquartered in Basel, Switzerland with additional offices in Boston, London, Munich, San Francisco, Singapore, and Tokyo.

http://www.genedata.com

LinkedIn | Twitter | YouTube

________________________________________

Contact

Allison Kurz

Genedata

Public Relations

pr@genedata.com

Disclaimer

The statements in this press release that relate to future plans, events, or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to contract cancellations, developing risks, competitive factors, uncertainties pertaining to customer orders, demand for products and services, development of markets for the Company’s products and services. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

All product and service names mentioned are the trademarks of their respective companies.

Share article on social media or email:



Creating Healthier Communities Recognized as “Best Company to Watch” in 2023


CHC recognized as one of the “50 best companies to watch” in 2023

“We’re rolling up our sleeves and partnering, community by community. And we won’t stop until no one experiences inequities,” said Dr. Jean Accius, CHC CEO.

Today, CHC: Creating Healthier Communities announced that The Silicon Review® recognized CHC as one of “50 Best Companies to Watch” for 2023. This award recognizes select organizations and highlights shared characteristics for success including consistent effort, ongoing innovation, and strategic planning. CHC was one of only a handful of nonprofits featured.

“CHC is indeed an organization to watch,” said Dr. Jean Accius, CHC president and CEO. “For nearly 70 years, CHC has been bringing nonprofits, businesses, and communities together around a shared commitment to better health and wellbeing and addressing the barriers to equity. Together, we are working hard to close the longevity gap, eliminate disparities, ensuring every person has equal access to opportunity, and bringing people in from the margins, to work together to build a more equitable and inclusive society. We’re rolling up our sleeves and partnering, community by community. And we won’t stop until no one experiences inequities.”

Check out the full list of “50 best companies to watch” as well as the feature interview about CHC. CHC supports more than 5,000 nonprofits annually plus has collaborative, trusted partnerships with hundreds of businesses, foundations, government entities and community-based organizations. The organization advances health equity through programs, community and volunteer engagement, fundraising, awareness, and support services. Health inequities cost $320 billion annually (WEF/Deloitte) and CHC is committed to finding common ground and bringing people together to solve these challenges.

“I couldn’t be prouder of this organization,” said Adam Rothschild, CHC board chair. “I’ve seen CHC evolve rapidly over the past few years into a major player and influencer in health equity. The future is bright for this organization and its partners in communities across the country. Together, we truly can help create healthier communities for all people.”

Earlier this year, CHC’s successful strategic transformation was highlighted in an independent case study, “10 Lessons in Organizational Transformation,” by the BBB Wise Giving Alliance.

“This important work requires co-creation and collaboration at all levels,” said Accius. “This is a clarion call for businesses—and all organizations—to come together with a common purpose to advance health equity,” said Accius. We invite business, government, and community leaders to join us. The time is now to take action for health equity for everyone.”

Take action by visiting chcimpact.org or emailing info@chcimpact.org.

ABOUT CHC: CREATING HEALTHIER COMMUNITIES

CHC: Creating Healthier Communities exists so that every person in every community has an opportunity to live their healthiest life. We leverage partnerships to raise funds, deliver programs and elevate solutions in communities. We focus on awareness and access, education and advocacy, and philanthropy. Together with partners, we’ve been creating healthier communities for nearly 70 years. Join us at chcimpact.org or @chcimpact.

Share article on social media or email:

Dental Care Alliance Welcomes Sparkling Smiles of Fayetteville, GA


“We are tremendously proud to introduce Drs. Lee and Polito and the entire team at Sparkling Smiles to the DCA family,” commented Mandy Gast, VP, Business Development for DCA

Dental Care Alliance (DCA) is pleased to welcome Sparkling Smiles, a two-doctor single location general practice located in Fayetteville, GA. Established in 1983 by Dr. Dave Lee, Dr. Lee continues to practice today with his daughter Dr. Lauren Polito.

Dr. Lee and Dr. Polito are dedicated to helping dental patients in Fayetteville maintain healthy and functional smiles. Not only do they provide judgment-free dental treatment, but they always take the time to hear their dentistry patients out and really understand their needs and worries. The practice prides itself on exceptional communication and world class customer service.

A driving core philosophy of the practice is to create long-lasting relationships with patients that is built on the foundation of maintaining good oral health. With their combined experience and their use of the latest technology and techniques in their field, the father daughter team is able to provide completely comprehensive top quality dental care for patients of all ages.

The full range of dental services offered by the practice include teeth cleaning and prevention, cosmetic dentistry (dentures, partials, teeth whitening), endodontics, periodontic care, restorative dentistry (filings, crowns, bridges), emergencies, extractions, root canals, Clear Aligners, sedation dentistry, gum disease, sleep apnea therapy, and TMJ Treatment.

When patients visit Dr. Lee and Dr. Lauren Lee Polito, DMD, they experience a dental office that doesn’t quite feel like a dental office, even though it is. The entire office is exceptionally welcoming and truly cares about the wellbeing of every patient.

Dr. Lee graduated with a Bachelor of Science from the University of Georgia. He received his Doctor of Dental Medicine from the Medical College of Georgia. He has since been a graduate of the Foundation for Advanced Continuing Education, the LD Pankey Institute, Las Vegas Institute and Baylor University’s Continuum of Contemporary Esthetic Diagnosis and Treatment.

Dr. Polito earned her dental degree from the Dental College of Georgia at Augusta University. After practicing in Colorado, New Mexico and France, she decided to return to her hometown to be closer to family.

“With DCA as an ally, I can now focus on my patients’ care and also have more time for my family,” shared Dr. Polito.

This affiliation continues the rapid growth and momentum for the organization and expands DCA’s footprint in Georgia to 22 allied practices, and DCA’s total footprint to over 400 allied practices across the US.

“We are tremendously proud to introduce Drs. Lee and Polito and the entire team at Sparkling Smiles to the DCA family,” commented Mandy Gast, VP, Business Development for DCA. “They have a sterling reputation in their community, share our commitment to clinical quality, patient experience, and desire for continued growth.”

Dental Care Alliance’s mission is to advance the practice of dentistry by partnering with and supporting dental professionals to create a lifetime of healthy smiles. DCA currently supports over 400 allied practices and supports over 900 dentists across 22 states. DCA’s allied practices represent all dental specialties and treat patients under more than 150 brand names.

Share article on social media or email:

symplr Appoints Hugo Doetsch as Chief Financial Officer


www.symplr.com

“We believe hospitals and health systems are seeking technology partners that help address their operational and efficiency needs. Leveraging Hugo’s experience, we will look to new growth opportunities for symplr and the healthcare organizations we support.” – BJ Schaknowski, CEO, symplr.

symplr®, a leading provider of enterprise healthcare operations software, has announced the appointment of Hugo Doetsch as Chief Financial Officer (CFO). Former CFO Jordan Copland is transitioning from full-time duties and will continue to support Doetsch and the finance team to ensure a smooth transition.

Doetsch joins symplr with over two decades of financial and operational experience leading financial operations at software companies at scale. Doetsch will be responsible for overseeing symplr’s financial operations and strategy and is expected to contribute to symplr’s growth and momentum.

“As volatility in the healthcare landscape continues, we believe hospitals and health systems are seeking technology partners that help address their operational and efficiency needs. By leveraging Hugo’s operational and Wall Street experience, we will look to develop new growth opportunities for symplr and the healthcare organizations we support,” said BJ Schaknowski, CEO of symplr. “On behalf of the entire Company, I would also like to thank Jordan for his many contributions to symplr as a member of the Executive Leadership Team over the past several years.”

Doetsch served as CFO of NetDocuments, a cloud-based content management platform for legal professionals, where he was named the CFO of the Year by Utah Business Magazine in 2022. NetDocuments was formerly Clearlake Capital-backed and symplr is a portfolio company of Clearlake Capital Group, L.P. (together with its affiliates, “Clearlake”) and Charlesbank Capital Partners, LLC (together with affiliates, “Charlesbank”).

Doetsch has a background as an operator, investment banker, and investor, leading strategic initiatives in various roles including with organizations like Citigroup and Citadel Securities. Previously he served as Head of Finance, Investor Relations, and Strategy & Corporate Development at Ping Identity, where he led its IPO in 2019. He earned his BS in Finance and BA in Economics from the University of Colorado Boulder.

“I am honored by the opportunity to build upon the foundation that BJ and his team have established over the last several years,” said Doetsch. “I believe symplr has built an impressive software portfolio that fulfills an often-neglected aspect of healthcare. I’m excited to join the team at this moment of growth and opportunity, and I look forward to partnering with symplr’s leaders, employees, valued customers, and the Clearlake and Charlesbank teams to continue to build operations and scale at the company.”

“Hugo is a respected member of the Clearlake family based upon his track record for helping to build growth businesses at scale and we are excited to be partnering with him again. His background and vision complement symplr’s customer-centric and growth-oriented strategy, and his financial and operating experience make him an ideal choice to join symplr’s leadership team,” said Prashant Mehrotra, symplr board member and Partner at Clearlake.

“We are confident that Hugo will add value as the Company continues to deliver on its mission of simplified operations in healthcare,” added Ryan Carroll, symplr board member and Managing Director at Charlesbank. “On behalf of Clearlake, Charlesbank, and symplr, we would like to thank Jordan for his leadership and dedication to the Company and wish him all the best in his future endeavors.”

To learn more about symplr and its mission to improve healthcare operations, please visit http://www.symplr.com.

About symplr

symplr is the leader in enterprise healthcare operations software and services. For more than 30 years and with deployments in 9 of 10 U.S. hospitals, symplr has been committed to improving healthcare operations through its cloud-based solutions, driving better operations for better outcomes. Our provider data management, workforce management, and healthcare governance, risk management, and compliance (GRC) solutions improve the efficiency and efficacy of healthcare operations, enabling caregivers to quickly handle administrative tasks so they have more time to do what they do best: provide high-quality patient care. Learn how at http://www.symplr.com.

About Clearlake Capital

Clearlake Capital Group, L.P. is an investment firm founded in 2006 operating integrated businesses across private equity, credit, and other related strategies. With a sector-focused approach, the firm seeks to partner with experienced management teams by providing patient, long-term capital to dynamic businesses that can benefit from Clearlake’s operational improvement approach, O.P.S.® The firm’s core target sectors are technology, industrials, and consumer. Clearlake currently has over $70 billion of assets under management and its senior investment principals have led or co-led over 400 investments. The firm is headquartered in Santa Monica, CA with affiliates in Dallas, TX, London, UK, Dublin, Ireland and Singapore. More information is available at http://www.clearlake.com and on Twitter @Clearlake.

About Charlesbank Capital Partners

Based in Boston and New York, Charlesbank Capital Partners is a middle-market private investment firm with more than $15 billion of capital raised since inception. Charlesbank focuses on management-led buyouts and growth capital financings, and engages in opportunistic credit and technology investments. The firm seeks to build companies with sustainable competitive advantage and excellent prospects for growth. For more information, please visit http://www.charlesbank.com.

Share article on social media or email:



Dallas Rhinoplasty Expert, Dr. Rod J. Rohrich, Delivers Keynote Lecture at Japanese Aesthetic Society Meeting


Dallas Rhinoplasty Surgeon Dr. Rod J. Rohrich

“Rhinoplasty remains one of the most challenging procedures in all of plastic surgery.” Dr. Rod J. Rohrich

Dallas rhinoplasty specialist, Dr. Rod J. Rohrich, was invited to deliver the keynote address at the Japanese Aesthetic Society meeting in Osaka Japan.

Dr. Rohrich spoke about his extensive experience performing rhinoplasty during his 30 year career and gave attendees guidance on how to develop consistency and excellence in rhinoplasty. He emphasized that the global principles of rhinoplasty remain the same but with enhanced techniques and technology the ability to learn and master rhinoplasty has been accelerated. He has developed numerous innovations and techniques that have changed how modern rhinoplasty is performed globally.

Dr. Rohrich was recently honored as the best rhinoplasty surgeon in the United States for the third consecutive year by Newsweek. He writes and lectures extensively on both rhinoplasty and revision rhinoplasty and believes that the new dorsal and tip shaping techniques which tension the nose add much more clarity on having better and more consistent rhinoplasty outcomes. He goes on to explain that this allows for improved and more uniform tip rotation and change in tip projection.

Dr. Rohrich, who advocates for the open approach to rhinoplasty which gives surgeons direct access to the delicate underlying nasal anatomy, stresses that each surgery must be customized to fit the patient’s unique circumstances, and minimizes the potential need for a revision rhinoplasty.

“Rhinoplasty remains one of the most challenging procedures in all of plastic surgery,” says Dr. Rohrich. “It is a surgery of millimeters, as the margin of error is very small. It truly epitomizes plastic surgery as a whole because it is a surgery of such great finesse and takes years to master.”

About Rod J. Rohrich, M.D., F.A.C.S.

Dr. Rod J. Rohrich is a board certified plastic surgeon in Dallas, Texas. He is considered one of the most influential surgeons in this century. He was named the top plastic surgeon in America by Newsweek in both rhinoplasty and facelift surgery in 2021, 2022 and 2023. Dr. Rohrich is a Clinical Professor of Plastic Surgery at Baylor College of Medicine. He was the first Chair of the Department of Plastic Surgery as well as the first plastic surgeon selected as a Distinguished Teaching Professor at UT Southwestern Medical Center. He graduated from Baylor College of Medicine with high honors, and completed his plastic surgery training at the University of Michigan Medical Center and fellowships at Massachusetts General Hospital/Harvard (hand/microsurgery) and Oxford University (pediatric plastic surgery). He is Chair of the Dallas Rhinoplasty Meeting, Founding Chair of the Dallas Cosmetic Surgery and Medicine Meeting, Founding Member of the Alliance in Reconstructive Surgery, and a Founding Partner of the Dallas Plastic Surgery Institute.

He is the immediate past (after serving for 18 years) Editor-in-Chief of the most respected global peer reviewed plastic surgery journal – the Plastic and Reconstructive Surgery Journal. He is Founding Editor-in-Chief/Editor Emeritus of the first open access peer reviewed plastic surgery journal, PRS Global Open. Dr. Rohrich has published over 1000 peer reviewed articles and seven textbooks in plastic surgery including a best-selling medical book entitled The Facial Danger Zones. Dr. Rohrich recently published an innovative cosmetic surgery video atlas, Cosmetic Surgery by the Masters.

Dr. Rohrich also served as president of the American Society of Plastic Surgeons (ASPS), the largest organization of board certified plastic surgeons in the world. He repeatedly has been selected by his peers as one of America’s best doctors. He received the ASPS Special Achievement Award and on three occasions has received one of his profession’s highest honors, the Plastic Surgery Foundation (PSF) Distinguished Service Award, which recognizes his contributions to education in plastic surgery. In addition, he has also been recognized by the PSF with the Plastic Surgery Foundation Distinguished Career Researcher Award for his contributions to plastic surgery research and innovations. He is also the recipient of the ASPS 2022 Honorary Citation.

Share article on social media or email: